155 related articles for article (PubMed ID: 16880534)
1. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.
Chiang MY; Xu ML; Histen G; Shestova O; Roy M; Nam Y; Blacklow SC; Sacks DB; Pear WS; Aster JC
Mol Cell Biol; 2006 Aug; 26(16):6261-71. PubMed ID: 16880534
[TBL] [Abstract][Full Text] [Related]
2. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
3. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.
Malecki MJ; Sanchez-Irizarry C; Mitchell JL; Histen G; Xu ML; Aster JC; Blacklow SC
Mol Cell Biol; 2006 Jun; 26(12):4642-51. PubMed ID: 16738328
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Paralog-Specific Notch1 Intracellular Domain Degron.
Broadus MR; Chen TW; Neitzel LR; Ng VH; Jodoin JN; Lee LA; Salic A; Robbins DJ; Capobianco AJ; Patton JG; Huppert SS; Lee E
Cell Rep; 2016 May; 15(9):1920-9. PubMed ID: 27210761
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1.
Popko-Scibor AE; Lindberg MJ; Hansson ML; Holmlund T; Wallberg AE
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):300-6. PubMed ID: 22100894
[TBL] [Abstract][Full Text] [Related]
6. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.
Gordon WR; Roy M; Vardar-Ulu D; Garfinkel M; Mansour MR; Aster JC; Blacklow SC
Blood; 2009 Apr; 113(18):4381-90. PubMed ID: 19075186
[TBL] [Abstract][Full Text] [Related]
7. Cyclin C is a haploinsufficient tumour suppressor.
Li N; Fassl A; Chick J; Inuzuka H; Li X; Mansour MR; Liu L; Wang H; King B; Shaik S; Gutierrez A; Ordureau A; Otto T; Kreslavsky T; Baitsch L; Bury L; Meyer CA; Ke N; Mulry KA; Kluk MJ; Roy M; Kim S; Zhang X; Geng Y; Zagozdzon A; Jenkinson S; Gale RE; Linch DC; Zhao JJ; Mullighan CG; Harper JW; Aster JC; Aifantis I; von Boehmer H; Gygi SP; Wei W; Look AT; Sicinski P
Nat Cell Biol; 2014 Nov; 16(11):1080-91. PubMed ID: 25344755
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes.
Nam Y; Sliz P; Song L; Aster JC; Blacklow SC
Cell; 2006 Mar; 124(5):973-83. PubMed ID: 16530044
[TBL] [Abstract][Full Text] [Related]
9. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.
Aster JC; Xu L; Karnell FG; Patriub V; Pui JC; Pear WS
Mol Cell Biol; 2000 Oct; 20(20):7505-15. PubMed ID: 11003647
[TBL] [Abstract][Full Text] [Related]
10. Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase.
Mo JS; Kim MY; Han SO; Kim IS; Ann EJ; Lee KS; Seo MS; Kim JY; Lee SC; Park JW; Choi EJ; Seong JY; Joe CO; Faessler R; Park HS
Mol Cell Biol; 2007 Aug; 27(15):5565-74. PubMed ID: 17526737
[TBL] [Abstract][Full Text] [Related]
11. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.
Ashworth TD; Pear WS; Chiang MY; Blacklow SC; Mastio J; Xu L; Kelliher M; Kastner P; Chan S; Aster JC
Blood; 2010 Dec; 116(25):5455-64. PubMed ID: 20852131
[TBL] [Abstract][Full Text] [Related]
12. Mutational and energetic studies of Notch 1 transcription complexes.
Del Bianco C; Aster JC; Blacklow SC
J Mol Biol; 2008 Feb; 376(1):131-40. PubMed ID: 18155729
[TBL] [Abstract][Full Text] [Related]
13. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.
Aster JC
Int J Hematol; 2005 Nov; 82(4):295-301. PubMed ID: 16298817
[TBL] [Abstract][Full Text] [Related]
14. Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
Karlsson A; Ungerbäck J; Rasmussen A; French JE; Söderkvist P
Int J Cancer; 2008 Dec; 123(11):2720-4. PubMed ID: 18798262
[TBL] [Abstract][Full Text] [Related]
15. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Weng AP; Ferrando AA; Lee W; Morris JP; Silverman LB; Sanchez-Irizarry C; Blacklow SC; Look AT; Aster JC
Science; 2004 Oct; 306(5694):269-71. PubMed ID: 15472075
[TBL] [Abstract][Full Text] [Related]
16. Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1.
Zhu W; Zhu Y; Xu H; Wang T; Wang J; Meng M; Liu Y; Yan H; Yang Q; Liu P
Biochem Biophys Res Commun; 2020 Feb; 522(3):684-689. PubMed ID: 31785807
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.
Oki T; Kitaura J; Watanabe-Okochi N; Nishimura K; Maehara A; Uchida T; Komeno Y; Nakahara F; Harada Y; Sonoki T; Harada H; Kitamura T
Leukemia; 2012 May; 26(5):1038-45. PubMed ID: 22116551
[TBL] [Abstract][Full Text] [Related]
18. Functional conservation of Notch1 and Notch2 intracellular domains.
Kraman M; McCright B
FASEB J; 2005 Aug; 19(10):1311-3. PubMed ID: 15897231
[TBL] [Abstract][Full Text] [Related]
19. The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway.
Krebs LT; Deftos ML; Bevan MJ; Gridley T
Dev Biol; 2001 Oct; 238(1):110-9. PubMed ID: 11783997
[TBL] [Abstract][Full Text] [Related]
20. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
Rodig SJ; Payne EG; Degar BA; Rollins B; Feldman AL; Jaffe ES; Androkites A; Silverman LB; Longtine JA; Kutok JL; Fleming MD; Aster JC
Am J Hematol; 2008 Feb; 83(2):116-21. PubMed ID: 17874453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
